UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Single-cell analysis of bronchoalveolar cells in inflammatory and fibrotic post-COVID lung disease

Frontiers in immunology, 2024-05, Vol.15, p.1372658-1372658

2024

Volltextzugriff (PDF)

1032 Early remodelling of CD4 T cell differentiation in lung squamous carcinogenesis

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1139-A1139

2023

Volltextzugriff (PDF)

Tracking down tumor-specific T cells

Cancer cell, 2022-04, Vol.40 (4), p.351-353

2022

Volltextzugriff (PDF)

Deep Learning Enables Spatial Mapping of the Mosaic Microenvironment of Myeloma Bone Marrow Trephine Biopsies

Cancer research (Chicago, Ill.), 2024-02, Vol.84 (3), p.493-OF16

2024

Volltextzugriff (PDF)

OAB-024: T cell differentiation in the bone marrow during disease evolution: insights from COSMOS and integrative analysis of 317,000 single-cell transcriptomes

Clinical lymphoma, myeloma and leukemia, 2022-08, Vol.22, p.S14-S15

2022

Volltextzugriff (PDF)

Developing a Flow Cytometric Signature of Carfilzomib Responsiveness in Myeloma

Blood, 2022-11, Vol.140 (Supplement 1), p.10106-10107

2022

Volltextzugriff (PDF)

P-389 Progression to myeloma reflects accelerating immunosenescence, loss of tumour MHC class I, and tumour growth-associated inflammation

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S255-S255

2023

Volltextzugriff (PDF)

P-241 Progression From Smouldering Myeloma to Myeloma Is Accompanied by an Increase in CD56bright Bone Marrow Resident NK Cells With Reduced NK Cell Cytotoxic Capacity

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S177-S177

2024

Volltextzugriff (PDF)

P-226 Study of T Cell Receptor (TCR) Dynamics in Smouldering Myeloma (SMM) Using TCR Sequence Clustering To Infer Contribution of the Immune Microenvironment to Progression to Multiple Myeloma (MM)

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S168-S168

2024

Volltextzugriff (PDF)

P-235 Isatuximab as Post-ASCT Therapy in MRDpositive Patients Augments CD8 Effector T Cell Differentiation: Insights from the UKMRA Phase 3 RADAR Study

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S173-S174

2024

Volltextzugriff (PDF)

P-219 Longitudinal Analysis of t(11; 14) and t(4; 14) Genomes Reveals Distinct Evolutionary Trajectories in Multiple Myeloma

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S163-S164

2024

Volltextzugriff (PDF)

OA-19 Marrow Immune Features Are Most Informative of Early MRD Negative Treatment Response in Newly Diagnosed TE Patients: Insights from the UKMRA Phase 3 RADAR Study

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S13-S13

2024

Volltextzugriff (PDF)

P-301 Evolving Disease in Smouldering Myeloma (SMM) Is Accompanied by Serial Change in Immune Marrow Composition

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S208-S209

2024

Volltextzugriff (PDF)

OAB-035: Characterising risk and biology Of smouldering myeloma for early detection of symptomatic myeloma: COSMOS, a prospective observational study in smouldering myeloma

Clinical lymphoma, myeloma and leukemia, 2022-08, Vol.22, p.S21

2022

Volltextzugriff (PDF)

P-390 The differentiation and expansion of T cell clonotypes in the bone marrow following ASCT: insights from the Phase 2 CARDAMON study

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S255-S256

2023

Volltextzugriff (PDF)

P-094 Characterising risk and biology of smouldering myeloma for early detection of symptomatic myeloma: data from the UK cosmos study

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S86-S87

2023

Volltextzugriff (PDF)

P-084: Bone marrow of patients post ASCT, but not chemotherapy consolidation, contains expanded T cell receptor clonotypes that are present at diagnosis: results from the Phase 2 CARDAMON study

Clinical lymphoma, myeloma and leukemia, 2022-08, Vol.22, p.S81-S82

2022

Volltextzugriff (PDF)

Uptake of long-chain fatty acids from the bone marrow suppresses CD8+ T-cell metabolism and function in multiple myeloma

Blood advances, 2023-10, Vol.7 (20), p.6035-6047

2023

Volltextzugriff (PDF)

Introducing corporate intranets: A descriptive study of business process and organizational response

Kane, Neil Foster

1999

Volltextzugriff (PDF)

Effects of a weight management program delivered by social media on weight and metabolic syndrome risk factors in overweight and obese adults: A randomised controlled trial

PloS one, 2017-06, Vol.12 (6), p.e0178326-e0178326

2017

Volltextzugriff (PDF)

The Role of Free-Living Daily Walking in Human Weight Gain and Obesity

Diabetes (New York, N.Y.), 2008-03, Vol.57 (3), p.548-554

2008

Volltextzugriff (PDF)

Interindividual Variation in Posture Allocation: Possible Role in Human Obesity

Science (American Association for the Advancement of Science), 2005-01, Vol.307 (5709), p.584-586

2005

Volltextzugriff (PDF)

Proteomics evaluation of five economical commercial abundant protein depletion kits for enrichment of diseases-specific biomarkers from blood serum

Proteomics (Weinheim), 2023-10, Vol.23 (20), p.e2300150-e2300150

2023

Volltextzugriff (PDF)

1 – 25 von 87

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(76)

Publikationsform

Sprache

Englisch
(87)

Erscheinungsjahr

n.n

Thema

Science & Technology
(51)
Life Sciences & Biomedicine
(49)
Humans
(37)
Oncology
(23)
Consensus
(19)
Peritoneal Neoplasms - Therapy
(19)
Chicago
(18)
Peritoneum
(17)
Female
(13)
Medicine
(13)
Surgery
(13)
Peritoneal Neoplasms - Secondary
(12)
Gastric Cancer
(11)
Malignancy
(11)
Practice Guidelines As Topic - Standards
(11)
Disease Management
(10)
Management
(10)
Medicine & Public Health
(10)
Physicians
(10)
Surgical Oncology
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Single-cell analysis of bronchoalveolar cells in inflammatory and fibrotic post-COVID lung disease

1032 Early remodelling of CD4 T cell differentiation in lung squamous carcinogenesis

Tracking down tumor-specific T cells

Deep Learning Enables Spatial Mapping of the Mosaic Microenvironment of Myeloma Bone Marrow Trephine Biopsies

High Neoantigen Load Confers a Major Benefit from Autologous Stem Cell Transplantation Compared to Consolidation in Newly Diagnosed Multiple Myeloma

OAB-024: T cell differentiation in the bone marrow during disease evolution: insights from COSMOS and integrative analysis of 317,000 single-cell transcriptomes

Tumor Reactive T Cells Reside in the Bone Marrow and Are Associated with Clinical Response to Hematological Malignancies

Developing a Flow Cytometric Signature of Carfilzomib Responsiveness in Myeloma

P-389 Progression to myeloma reflects accelerating immunosenescence, loss of tumour MHC class I, and tumour growth-associated inflammation

P-241 Progression From Smouldering Myeloma to Myeloma Is Accompanied by an Increase in CD56bright Bone Marrow Resident NK Cells With Reduced NK Cell Cytotoxic Capacity

P-226 Study of T Cell Receptor (TCR) Dynamics in Smouldering Myeloma (SMM) Using TCR Sequence Clustering To Infer Contribution of the Immune Microenvironment to Progression to Multiple Myeloma (MM)

P-235 Isatuximab as Post-ASCT Therapy in MRDpositive Patients Augments CD8 Effector T Cell Differentiation: Insights from the UKMRA Phase 3 RADAR Study

P-219 Longitudinal Analysis of t(11; 14) and t(4; 14) Genomes Reveals Distinct Evolutionary Trajectories in Multiple Myeloma

OA-19 Marrow Immune Features Are Most Informative of Early MRD Negative Treatment Response in Newly Diagnosed TE Patients: Insights from the UKMRA Phase 3 RADAR Study

P-301 Evolving Disease in Smouldering Myeloma (SMM) Is Accompanied by Serial Change in Immune Marrow Composition

OAB-035: Characterising risk and biology Of smouldering myeloma for early detection of symptomatic myeloma: COSMOS, a prospective observational study in smouldering myeloma

P-390 The differentiation and expansion of T cell clonotypes in the bone marrow following ASCT: insights from the Phase 2 CARDAMON study

P-094 Characterising risk and biology of smouldering myeloma for early detection of symptomatic myeloma: data from the UK cosmos study

P-084: Bone marrow of patients post ASCT, but not chemotherapy consolidation, contains expanded T cell receptor clonotypes that are present at diagnosis: results from the Phase 2 CARDAMON study

Uptake of long-chain fatty acids from the bone marrow suppresses CD8+ T-cell metabolism and function in multiple myeloma

Introducing corporate intranets: A descriptive study of business process and organizational response

Effects of a weight management program delivered by social media on weight and metabolic syndrome risk factors in overweight and obese adults: A randomised controlled trial

The Role of Free-Living Daily Walking in Human Weight Gain and Obesity

Interindividual Variation in Posture Allocation: Possible Role in Human Obesity

Proteomics evaluation of five economical commercial abundant protein depletion kits for enrichment of diseases-specific biomarkers from blood serum

Suchergebnisse filtern